ZOCILURTATUG PELITECAN
UNII 947N9WVZ4A

Substance Identification & Data

This profile provides standardized clinical and technical data for Zocilurtatug Pelitecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 947N9WVZ4A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3058592-88-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

947N9WVZ4A

CAS Registry Number

3058592-88-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZOCILURTATUG PELITECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13884

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OP-61

Identifier assigned by the United States Adopted Names Council.

Substance Type

Zocilurtatug Pelitecan

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zocilurtatug Pelitecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Zocilurtatug Pelitecan

Common Names & Synonyms

H-gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV1-2*02 (86.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*01 (100%) G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-disulfide with L-kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-27*01 (82.1%) -IGKJ2*01 (91.7%) L124>V (104'), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa; substituted at the sulfur atoms of an average of eight L-cysteinyl residues amomg 223, 229, 232, 214', 223'', 229'', 232'' and 214''' with 5-[(11S,14S)-11-[4-(dipropylamino)butyl]-1-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl]-7,10,13,16-tetraoxo-14-(propan-2-yl)-4-oxa-6,9,12,15-tetraazahenicos-20-yn-21-yl]pyrimidin-2-yl (pelitecan) groups

Immunoglobulin G1, anti-(human/Macaca fascicularis notch ligand DLL3) (human-Mus musculus monoclonal YL212 γ1-chain), complex with human-Mus musculus monoclonal YL212 κ-chain, dimer, octakis(thioether) with N-[6-(2-mercapto-5-pyrimidinyl)-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]glycinamide

ZL-1310 (recombinant humanized IgG1 anti-DLL3 monoclonal antibody conjugated to YL0010014)

ZOCILURTATUG PELITECAN [USAN]

Zocilurtatug pelitecan [WHO-DD]

immunoglobulin G1-kappa, anti-[Homo sapiens DLL3 (delta-like ligand 3, delta like canonical Notch ligand 3)], humanized monoclonal antibody, conjugated on an average of eight cysteinyl residues to pelitecan groups, comprising a linker and a camptothecin derivative (zocilurtatug pelitecan)

zocilurtatug pelitecan [INN]

Technical Codes

YL-212

YL212

ZL-1310

External Clinical & Regulatory Resources

Previous UNII947L2CLK4S

Next UNII947O3MC76M